Pivotal phase IIb trial of brivudine in patients with advanced pancreatic cancer.
Phase of Trial: Phase II
Latest Information Update: 08 Feb 2016
At a glance
- Drugs Brivudine (Primary)
- Indications Pancreatic cancer
- Focus Registrational; Therapeutic Use
- Sponsors RESprotect
- 08 Feb 2016 According to a RedHill Biopharma media release, brivudine has received Orphan Drug Designation for the adjunct treatment of pancreatic cancer by the US FDA and the EMA.
- 30 Jun 2011 New trial record